All News

Indicating for preventing pregnancy, a statement from the FDA said that loss of efficacy is possible if the user misses tablets.

The 2017 Health Care Cost and Utilization Report examined medical and prescription drug spending, utilization, and average prices using health care claims data from 2013 through 2017 for Americans under the age of 65 who were covered by employer-sponsored insurance.

Specialty pharmacies and their patients now require technology systems that are more sophisticated in nature than the basic functions used in the past.

First of its kind study suggests commonalities for humans, dogs, and horses with melanoma.

What is causing this woman's anxiety, trembling hands, and sweating?

This medication, indicated for individuals with diabetes, will have a list price that is 50% lower than its current list price.

There are financial implications and a significant commitment of time, effort, and energy to implement a health system specialty pharmacy.

Top news of the day from across the health care landscape.

Tildrakizumab was approved by the FDA as a subcutaneous therapy for patients with moderate-to-severe psoriasis.

Many women are unaware of HIV pre-exposure prophylaxis (PrEP) but show a keen interest in spreading the word once they learn about the option, according a recent study in the journal Contraception.

Investigators from the CDC Human Papillomavirus (HPV) Vaccine Impact Monitoring Project (HPV-IMPACT) sought to determine whether HPV types 16 and 18, which are responsible for approximately 70% of cervical cancers worldwide, are also decreasing.

Analysis of care in a routine clinical practice setting show that 40-week treatment of biologic dupilumab (Dupixent, Sanofi-Regeneron) plus noncosmetic topical moisturizer (emollient) is associated with significantly improved symptoms and health-related quality of life (HRQoL) in particular patients with atopic dermatitis (AD).

A large retrospective study of patients with acne found no significant association between isotretinoin exposure and depression.

The recalled losartan potassium tablets made by Hetero Labs and distributed by Camber Pharmaceuticals contain the impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), which is a known animal and potential human carcinogen.

Novo Nordisk is seeking approval for fast-acting insulin aspart (Fiasp) as a new mealtime insulin for children and adolescents with type 1 diabetes.

The agency urges the public to receive a vaccine if they have not already done so.

The drug's approval was based on 4 clinical studies evaluating the efficacy and safety of Adhansia XR in 883 people who met DSM-5 criteria for ADHD.

According to the agency, these drugs are potentially dangerous to consumers in the United States.

The report analyzed cost and utilization trends across health care services among patients with employer-sponsored insurance.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Study finds that glecaprevir/pibrentasvir pan-genotypic efficacy for hepatitis C virus is achieved regardless of whether patients are concurrently receiving gastric acid-reducing drugs.

The research centers on CD8+ T cells, which can recognize and attack the influenza virus.

The new formulation will provide patients with a faster alternative for management of suspected myocardial infarction.

Indivior’s once-monthly schizophrenia treatment risperidone (Perseris) extended-release injectable suspension has launched in the United States.